Correction of Farsightedness in Children Study

NCT ID: NCT00472212

Last Updated: 2023-04-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-11-30

Study Completion Date

2008-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Correction of Hyperopia In Children Study (CHICS) is a placebo-controlled, randomized, masked investigation of the effect of spectacle correction for moderate amounts of hyperopia on visual function, attention, and reading skills in children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hyperopia (farsightedness) has been reported to be associated with reduced visual perceptual and reading abilities. However, there is controversy regarding whether or not to prescribe for low to moderate amounts of hyperopia. The Correction of Hyperopia In Children Study (CHICS) is a placebo-controlled, randomized, masked investigation of the effect of spectacle correction for moderate amounts of hyperopia on visual function, attention, and reading skills in children.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperopia Farsightedness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Spectacles

Spectacles with hyperopic lenses

Group Type EXPERIMENTAL

Spectacles

Intervention Type DEVICE

Hyperopic spectacle lenses

Control

Spectacles with placebo lenses

Group Type PLACEBO_COMPARATOR

Control

Intervention Type DEVICE

Plano (no power, control) spectacle lenses

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Spectacles

Hyperopic spectacle lenses

Intervention Type DEVICE

Control

Plano (no power, control) spectacle lenses

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 6-11 years;
* At least +1.00D Hyperopia (farsightedness);
* \< +4.00D Hyperopia;
* \< 1.00D Astigmatism;
* \< 1.00D Anisometropia (difference between the two eyes);
* Willing to be randomized;
* Best corrected visual acuity of 20/25 or better in each eye;
* Willing to wear eyeglasses full-time;
* Willing to return for follow-up visits

Exclusion Criteria

* Previous wear of glasses or contacts for farsightedness/hyperopia;
* Eye disease that affects visual function;
* Amblyopia (lazy eye);
* Strabismus (eye turn);
* History of strabismus surgery;
* Chronic use of any of the following medications:

* Antianxiety agents (Librium, Valium)
* Antiarrythmic agents (Cifenline, Cibenzoline)
* Anticholinergics (Motion sickness patch - scopolamine)
* Bladder spasmolytic (Propiverine)
* Chloroquine
* Phenothiazines (Compazine, Mellaril, Thorazine)
* Tricyclic antidepressants (Elavil, Nortriptyline, Tofranil)
Minimum Eligible Age

6 Years

Maximum Eligible Age

11 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

American Academy of Optometry

OTHER

Sponsor Role collaborator

Transitions

INDUSTRY

Sponsor Role collaborator

Ohio Lions Eye Research Foundation

OTHER

Sponsor Role collaborator

College of Optometrists in Vision Development

OTHER

Sponsor Role collaborator

SUNY Research Foundation

OTHER

Sponsor Role collaborator

Ohio State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marjean Kulp

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marjean Kulp, OD

Role: PRINCIPAL_INVESTIGATOR

Ohio State University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Illinois College of Optometry/Illinois Eye Institute

Chicago, Illinois, United States

Site Status

SUNY College of Optometry/University Optometric Center

New York, New York, United States

Site Status

The Ohio State University

Columbus, Ohio, United States

Site Status

Southern College of Optometry

Memphis, Tennessee, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2001H0401

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CYPRESS Efficacy and Safety Study Extension
NCT04947735 ACTIVE_NOT_RECRUITING NA
Myopia Prevention With Reading Glasses
NCT05030103 NOT_YET_RECRUITING NA
Early Intervention for Premyopic Children
NCT06200194 ACTIVE_NOT_RECRUITING PHASE2